Literature DB >> 27538663

The use of medical-grade cannabis in patients non-responders to Nabiximols.

Francesco Saccà1, Chiara Pane2, Antonio Carotenuto2, Marco Massarelli2, Roberta Lanzillo2, Ettore Brunello Florio3, Vincenzo Brescia Morra2.   

Abstract

Entities:  

Keywords:  Bedrocan; Cannabis; Nabiximols; Sativex; THC, Spasticity

Mesh:

Substances:

Year:  2016        PMID: 27538663     DOI: 10.1016/j.jns.2016.07.059

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


× No keyword cloud information.
  2 in total

1.  The use of medical grade cannabis in Italy for drug-resistant epilepsy: a case series.

Authors:  Chiara Pane; Francesco Saccà
Journal:  Neurol Sci       Date:  2019-11-27       Impact factor: 3.307

Review 2.  Targeting Cannabinoid Signaling in the Immune System: "High"-ly Exciting Questions, Possibilities, and Challenges.

Authors:  Attila Oláh; Zoltán Szekanecz; Tamás Bíró
Journal:  Front Immunol       Date:  2017-11-10       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.